Host Ankit Nanda, FSA, MAAA, FCA, speaks with Nicky Draper, HonFIA, Director of Life & Health Consulting at Crystallise and a former intensive care nurse and public health specialist, about what lies beneath a smooth mortality trend: frailty, delayed diagnosis, access to care and multi-morbidity. The conversation covers type 2 diabetes and obesity, GLP-1 drugs and their wider effects, how the UK's NICE weighs the cost of new treatments including cell and gene therapies, lessons from the COVID-19 Actuaries Response Group for the next pandemic, antimicrobial resistance, health inequalities, and the biology of aging. It closes on why actuaries should stay curious about the mechanisms behind the trends.